Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morrow

Showing results (551-560 of 773) with videos related to

Pageof 78
Sort By:
Molecular Pharmacology|September 28, 2007
In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducersMiroslav Dostalek, Joshua D Brooks, Klarissa D Hardy, et al.
The Journal of Biological Chemistry|June 5, 1998
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acidL J Roberts, T J Montine, W R Markesbery, et al.
Psychopharmacology|June 5, 2020
Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attributionAli Gheidi, Lora M Cope, Christopher J Fitzpatrick, et al.
Journal of the American College of Nutrition|April 1, 1992
Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunctionI R Bell, J S Edman, F D Morrow, et al.
Free Radical Biology & Medicine|February 3, 2005
Degree of heteroplasmy reflects oxidant damage in a large family with the mitochondrial DNA A8344G mutationJeffrey A Canter, Alex Eshaghian, Joshua Fessel, et al.
Cancer Research|December 15, 1994
Characterization of poliovirus replicons encoding carcinoembryonic antigenD C Ansardi, Z Moldoveanu, D C Porter, et al.
Journal of Lipid Mediators|March 1, 1993
Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndromeJ D Morrow, K P Moore, J A Awad, et al.
The Biochemical Journal|November 18, 2003
Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation productsAnna-Liisa Levonen, Aimee Landar, Anup Ramachandran, et al.
Beneficial Microbes|April 1, 2021
Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controlsK S Smith, A D Frugé, W van der Pol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Pageof 78

Showing results (551-560 of 773) with videos related to

Sort By:
Pageof 78
Molecular Pharmacology|September 28, 2007
In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducersMiroslav Dostalek, Joshua D Brooks, Klarissa D Hardy, et al.
The Journal of Biological Chemistry|June 5, 1998
Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acidL J Roberts, T J Montine, W R Markesbery, et al.
Psychopharmacology|June 5, 2020
Effects of the cannabinoid receptor agonist CP-55,940 on incentive salience attributionAli Gheidi, Lora M Cope, Christopher J Fitzpatrick, et al.
Journal of the American College of Nutrition|April 1, 1992
Brief communication. Vitamin B1, B2, and B6 augmentation of tricyclic antidepressant treatment in geriatric depression with cognitive dysfunctionI R Bell, J S Edman, F D Morrow, et al.
Free Radical Biology & Medicine|February 3, 2005
Degree of heteroplasmy reflects oxidant damage in a large family with the mitochondrial DNA A8344G mutationJeffrey A Canter, Alex Eshaghian, Joshua Fessel, et al.
Cancer Research|December 15, 1994
Characterization of poliovirus replicons encoding carcinoembryonic antigenD C Ansardi, Z Moldoveanu, D C Porter, et al.
Journal of Lipid Mediators|March 1, 1993
Marked overproduction of non-cyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndromeJ D Morrow, K P Moore, J A Awad, et al.
The Biochemical Journal|November 18, 2003
Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation productsAnna-Liisa Levonen, Aimee Landar, Anup Ramachandran, et al.
Beneficial Microbes|April 1, 2021
Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controlsK S Smith, A D Frugé, W van der Pol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxelIldiko Csiki, Jason D Morrow, Alan Sandler, et al.
Pageof 78